Literature DB >> 11104576

Timing within the oestrous cycle modulates adrenergic suppression of NK activity and resistance to metastasis: possible clinical implications.

S Ben-Eliyahu1, G Shakhar, K Shakhar, R Melamed.   

Abstract

Clinical observations suggest that the rate of metastatic development and long-term mortality following surgery in breast cancer patients is influenced by the menstrual phase during which surgery is conducted. The menstrual cycle is known to modulate various physiological responses and medical conditions that involve adrenergic mechanisms (e.g., asthma). Natural killer activity (NKA), an immune function controlling metastasis, is suppressed following surgery, and in vitro by adrenaline. We therefore hypothesize that the clinical observation may be partly attributable to surgery-induced adrenergic suppression of NK-dependent resistance to metastasis, a suppression that depends on menstrual phase during surgery. To test this hypothesis in rats, 140 F344 females at different phases of their oestrous cycle were injected with a beta-adrenergic agonist, metaproterenol (MP) (0.4 or 0.8 mg kg(-1), s.c.), or with vehicle, before i.v. inoculation with MADB106 tumour cells. This syngeneic mammary adenocarcinoma line metastasizes only to the lungs, and is highly sensitive to NKA. In a second experiment, the suppression of NKA by MP was studied in vitro in blood drawn at different phases of the oestrous cycle (n = 36). Finally, the effects of stress on the number and activity of NK cells were assessed along the oestrous cycle (n = 71). The findings indicate that the suppressive effects of MP on resistance to metastasis and on NKA, are significantly greater during the oestrous phase characterized by high oestradiol levels (D3/proestrus/oestrus). Similarly, NKA per cell was suppressed by stress only during this phase. In untreated animals, in which inadvertent stress was minimized, no effects of the oestrous cycle on NKA or on resistance to metastasis were evident. These findings indicate that the oestrous cycle modulates adrenergic suppression of NKA and of resistance to metastasis. The relevance of these findings to the above clinical observation, as well as that of our related findings in women from a parallel study, is discussed. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104576      PMCID: PMC2363471          DOI: 10.1054/bjoc.2000.1563

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Increased surgery-induced metastasis and suppressed natural killer cell activity during proestrus/estrus in rats.

Authors:  G G Page; S Ben-Eliyahu
Journal:  Breast Cancer Res Treat       Date:  1997-09       Impact factor: 4.872

2.  Cardiovascular, endocrine, and receptor measures as related to sex and menstrual cycle phase.

Authors:  B Litschauer; S Zauchner; K H Huemer; A Kafka-Lützow
Journal:  Psychosom Med       Date:  1998 Mar-Apr       Impact factor: 4.312

3.  Timing of breast cancer surgery during the luteal menstrual phase may improve prognosis.

Authors:  H M Lemon; J F Rodriguez-Sierra
Journal:  Nebr Med J       Date:  1996-04

4.  CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause.

Authors:  H D White; K M Crassi; A L Givan; J E Stern; J L Gonzalez; V A Memoli; W R Green; C R Wira
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Loss of normal cyclical beta 2 adrenoceptor regulation and increased premenstrual responsiveness to adenosine monophosphate in stable female asthmatic patients.

Authors:  K S Tan; L C McFarlane; B J Lipworth
Journal:  Thorax       Date:  1997-07       Impact factor: 9.139

6.  Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity.

Authors:  S Ben-Eliyahu; G G Page; R Yirmiya; G Shakhar
Journal:  Int J Cancer       Date:  1999-03-15       Impact factor: 7.396

7.  In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats.

Authors:  G Shakhar; S Ben-Eliyahu
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

8.  Release of immunosuppressive substances after gastric resection is more prolonged than after mastectomy in humans.

Authors:  T Shirakawa; A Tokunaga; M Onda
Journal:  Int Surg       Date:  1998 Jul-Sep

Review 9.  Natural killer cells and cancer.

Authors:  J Brittenden; S D Heys; J Ross; O Eremin
Journal:  Cancer       Date:  1996-04-01       Impact factor: 6.860

10.  Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells.

Authors:  S Ben-Eliyahu; G G Page; G Shakhar; A N Taylor
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

View more
  10 in total

1.  Continuous stress disrupts immunostimulatory effects of IL-12.

Authors:  Ben Levi; Marganit Benish; Yael Goldfarb; Liat Sorski; Rivka Melamed; Ella Rosenne; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2011-01-28       Impact factor: 7.217

Review 2.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

Review 3.  Harnessing cancer immunotherapy during the unexploited immediate perioperative period.

Authors:  Pini Matzner; Elad Sandbank; Elad Neeman; Oded Zmora; Vijaya Gottumukkala; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2020-02-17       Impact factor: 66.675

4.  Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females.

Authors:  S Haim; G Shakhar; E Rossene; A N Taylor; S Ben-Eliyahu
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

Review 5.  Beta-Adrenergic Signaling in Tumor Immunology and Immunotherapy.

Authors:  Wei Wang; Xuefang Cao
Journal:  Crit Rev Immunol       Date:  2019       Impact factor: 2.214

6.  Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity.

Authors:  K Shakhar; G Shakhar; E Rosenne; S Ben-Eliyahu
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

Review 7.  Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine.

Authors:  Silvia Capellino; Maren Claus; Carsten Watzl
Journal:  Cell Mol Immunol       Date:  2020-06-05       Impact factor: 11.530

8.  Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update.

Authors:  Anushka Chaudhry; Michael L Puntis; Panos Gikas; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2006-11-01

9.  Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses.

Authors:  Marganit Benish; Shamgar Ben-Eliyahu
Journal:  Cancers (Basel)       Date:  2010-11-24       Impact factor: 6.639

Review 10.  Highlighting the Potential for Chronic Stress to Minimize Therapeutic Responses to Radiotherapy through Increased Immunosuppression and Radiation Resistance.

Authors:  Minhui Chen; Anurag K Singh; Elizabeth A Repasky
Journal:  Cancers (Basel)       Date:  2020-12-20       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.